Dapo Ilo

Upadacitinib Therapy Reduces Ulcerative Colitis Symptoms as Early as Day 1 of Induction Treatment

Edward V. Loftus, Jean‐Frédéric Colombel, Ken Takeuchi et al. · Clinical Gastroenterology and Hepatology · 2022 · 86 citations · Full text

Inflammation, Anti-inflammatory, Day 1 +5

Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis

Remo Panaccione, Eric B. Collins, Gil Melmed et al. · Crohn s & Colitis 360 · 2023 · 55 citations · Full text

Efficacy and safety of upadacitinib maintenance therapy for moderately to severely active ulcerative colitis in patients responding to 8 week induction therapy (U-ACHIEVE Maintenance): overall results from the randomised, placebo-controlled, double-blind, phase 3 maintenance study

Séverine Vermeire, Silvio Danese, Wen Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 42 citations

Upadacitinib Maintenance Therapy, Gastroenterology, Clinical Gastroenterology +5

Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)

Andrew Blauvelt, Kim Papp, C.E.M. Griffiths et al. · American Journal of Clinical Dermatology · 2017 · 38 citations · Full text

Clinical Trials, Clinical Dermatology, Moderate-to-severe Plaque Psoriasis +6

Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis

Gareth Parkes, Ryan C. Ungaro, Silvio Danese et al. · Journal of Gastroenterology · 2023 · 26 citations · Full text